Scientific Publications & Abstracts
Scientific Publications
Harsányi L, Kincses Z, Altorjay A.
Treating Acid Reflux Without Compressing the Food Passageway: 3-year Outcomes with the RefluxStop™ Implant. Z Gastroenterol 2023; 61(08): e401 DOI: 10.1055/s-0043-1771713
Available at:
https://www.thieme-connect.de/products/ejournals/abstract/10.1055/s-0043-1771713
Harper S, Kartha M, Borbély Y, Zehetner J, Mealing S.
Analysis of Cost-Effectiveness in Switzerland for a New Implantable Device to Treat Chronic Gastroesophageal Reflux Disease. Value in Health. 26;11(S2):December 2023.
Available at:
1. https://www.valueinhealthjournal.com/article/S1098-3015(23)04028-7/fulltext
2. https://www.ispor.org/heor-resources/presentations-database/presentation/euro2023-3788/133117
Lundell L, Kartha M, Harper S, Mealing S.
Cost-Effectiveness Analysis of an Implantable Device for Chronic Gastro-Oesophageal Reflux Disease in Sweden. Value in Health. 26;11(S2):December 2023.
Available at:
1. https://www.valueinhealthjournal.com/article/S1098-3015(23)03876-7/fulltext
2. https://www.ispor.org/heor-resources/presentations-database/presentation/euro2023-3787/130704
Stuart Mealing, Sam Harper, Lukasz Grodzicki, Liz Gemmill, Paul Goldsmith, Ahmed Ahmed
OGBN P15 The cost-effectiveness of a novel implantable device for treating gastro-oesophageal reflux disease in the United Kingdom, British Journal of Surgery, Volume 110, Issue Supplement_8, November 2023, znad348.107,
Available at:
https://doi.org/10.1093/bjs/znad348.107
Lehmann T, Simkus M, Oehler C.
Topic: Endoscopic Foregut Surgery (Including Endobariatrics) Abstract ID: 82 A Retrospective Chart Review of 79 Patients Undergoing the RefluxStop™ Procedure to Manage Gastroesophageal Reflux Disease: Safety and Efficacy. Foregut. 2023;3(3):401-401. doi:10.1177/26345161231196002
Available at:
Click here to read the PDF
Harper S, Grodzicki L, Mealing S, Gemmill E, Goldsmith P, Ahmed A.
Budget Impact of RefluxStop™ as a Treatment for Patients with Refractory Gastro-oesophageal Reflux Disease in the United Kingdom. J Health Econ Outcomes Res. 2024;11(1):1-7. Published 2024 Jan 11. doi:10.36469/001c.90924
Available at:
https://pubmed.ncbi.nlm.nih.gov/38222857/
Fringeli Y, Linas I, Kessler U, Zehetner J.
Laparoscopic Large Hiatal Hernia Repair With RefluxStop™: Outcomes of Six Months Follow-up in Thirty Patients. Surg Laparosc Endosc Percutan Tech. Published online February 29, 2024. doi:10.1097/SLE.0000000000001256
Available at:
https://pubmed.ncbi.nlm.nih.gov/38421213/
Fringeli Y, Linas I, Kessler U, Zehetner J.
Short-term results of laparoscopic anti-reflux surgery with the RefluxStop™ device in patients with gastro-esophageal reflux disease and ineffective esophageal motility. Langenbecks Arch Surg. 2024;409(1):78. Published 2024 Feb 29. doi:10.1007/s00423-024-03264-5
Available at:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10901965/
Thorsten Lehmann, Mantas Simkus, Christoph Oehler,
264. A retrospective chart review of 85 patients undergoing the RefluxStop™ procedure to manage gastroesophageal reflux disease: Safety and efficacy, Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.105, https://doi.org/10.1093/dote/doad052.105
Available at:
https://academic.oup.com/dote/article/36/Supplement_2/doad052.105/7253601?searchresult=1
Lehman TG, Simkus M, Oehler C.
Retrospective chart review of 79 subjects with gastroesophageal reflux disease managed with the RefluxStop™ procedure: A report of the safety and efficacy (2023), UEG Week 2023 Poster Presentations. United European Gastroenterol J, 11: 535-1498.
Available at:
https://onlinelibrary.wiley.com/doi/abs/10.1002/ueg2.12461
Yves Borbély, Dino Kroell, Claudine Di Pietro Martinelli, Tobias Haltmeier, Gian Prevost,
442. RefluxStop™ procedure as a novel technique for management of gastroesophageal reflux disease: Two-year follow-up data at a hospital in Switzerland, Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.233, https://doi.org/10.1093/dote/doad052.233
Available at:
https://academic.oup.com/dote/article/36/Supplement_2/doad052.233/7253475?login=false
Hoffsten J, Das S, Kartha M.
EE479 The Cost of Treating Gastroesophageal Reflux Disease: A Systematic Review. Value in Health. 2023;26(12):S143. DOI: https://doi.org/10.1016/j/jval/2023.09.745
Available at:
Click here to read the PDF
Goldsmith P, Das S, Hoffsten J.
OGBN O03 Quality of life of patients with gastroesophageal reflux disease: findings from a systematic literature review. British Journal of Surgery. 2023;110(S8):November 2023. znad348.025. https://doi.org/10.1093/bjs/znad348.025
Available at:
https://academic.oup.com/bjs/article/110/Supplement_8/znad348.025/7428861
Goldsmith M, Das S, Hoffsten J.
CO45 A Systematic Review of Quality of Life and Gastroesophageal Reflux Disease. Value in Health. 2023;26(12):S22. DOI: https://doi.org/10.1016/j.jval.2023.09.117
Available at:
Click here to read the PDF
1 Year Landmark Study Results:
According to investigation results the principle of RefluxStop™ is safe and effective to treat Gastroesophageal reflux disease (GERD).
This research article published on BMC Surgery Journal gives you more information on how RefluxStop™ performed during a clinical investigation study group conducted in 2020.
Bjelović M, Harsányi L, Altorjay Á, Kincses Z, Forsell P; Investigators of the RefluxStop™ Clinical Investigation Study Group.
Non-active implantable device treating acid reflux with a new dynamic treatment approach: 1-year results. BMC Surg. 2020;20(1):159. doi: 10.1186/s12893-020-00794-9. PMID: 32689979; PMCID: PMC7370422.
Available at:
1. https://pubmed.ncbi.nlm.nih.gov/32689979/
2. https://bmcsurg.biomedcentral.com/articles/10.1186/s12893-020-00794-9
Harper S, Grodzicki L, Mealing S, Gemmill L, Goldsmith PJ, Ahmed AR.
Cost-effectiveness of a novel, non-active implantable device as a treatment for refractory gastro-esophageal reflux disease. J Med Econ. 2023;26(1):603-613. doi: 10.1080/13696998.2023.2201063. PMID: 37042668.
Available at:
1. https://pubmed.ncbi.nlm.nih.gov/37042668/
2. https://www.tandfonline.com/doi/full/10.1080/13696998.2023.2201063
Stephan D, Borbély Y, Schoppmann SF.
RefluxStop™ Therapy – a New Minimally Invasive Technology in Anti-reflux Surgery. Surg Technol Int. 2022;41:sti41/1622. Epub ahead of print. PMID: 36255718.
Available at:
1. https://pubmed.ncbi.nlm.nih.gov/36255718/
2. https://surgicaltechnology.com/41-General-Surgery.htm#1622
Fringeli Y, Kessler U, Linas I, Zehetner J.
https://doi.org/10.1093/bjs/znad178.020
Abstracts
Borbély YM, Kroell D, DiPietro C, Haltmeier T, Prevost GA.
RefluxStop – a novel device to address Gastroesophageal Reflux Disease. Presented at: 2023 Annual Meeting of the Society of American Gastrointestinal and Endoscopic Surgeons; March 30, 2023; Montreal, Canada. Abstract ID: 129788.
Reflux Patients with Ineffective Esophageal Motility: 12-Month Follow-up Results of Laparoscopic Hiatal Hernia Repair with RefluxStop
Prof. Dr. Joerg Zehetner
DDW ePoster Library. Zehetner J. 05/08/2023; 377862; Mo1339
Available at:
https://eposters.ddw.org/ddw/2023/ddw-2023/377862/joerg.zehetner.gerd.patients.with.ineffective.esophageal.motility.3Cbr3E.html?f=menu%3D6%2Abrowseby%3D8%2Asortby%3D2%2Amedia%3D2%2Ace_id%3D2482%2Aot_id%3D27745%2Amarker%3D4154
Borbély Y.
RefluxStop - a novel surgical device to address gastroesophageal reflux disease: Data from two-year follow-up at a tertiary level hospital in Switzerland. Presented at Kirurgveckan 2023. Örebro, Sweden. August 21-25, 2023.
Elshafei M.
One-year follow-up of 15 patients with gastroesophageal reflux disease managed with the novel RefluxStop device. Presented at Høstmøtet 2023. Oslo, Norway. October 23-27, 2023.
Gaupset R, Eftang L.
Cost-effectiveness assessment of RefluxStop for refractory gastroesophageal reflux disease in Norway. Presented at Høstmøtet 2023. Oslo, Norway. October 23-27, 2023.